Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.33%2.5B | -13.78%4.92B | --2.4B | 34.80%5.7B | 52.96%1.25B | 16.12%4.23B | --814.73M | 237.40%3.64B | --1.08B |
| Operating income | 4.33%2.5B | -13.78%4.92B | 2.4B | 34.80%5.7B | 52.96%1.25B | 16.12%4.23B | 814.73M | 237.40%3.64B | 1.08B |
| Cost of sales | -3.00%-1.68B | 9.55%-3.38B | ---1.64B | -34.77%-3.74B | -52.44%-807.49M | -18.45%-2.78B | ---529.69M | -242.88%-2.34B | ---683.37M |
| Operating expenses | -3.00%-1.68B | 9.55%-3.38B | -1.64B | -34.77%-3.74B | -52.44%-807.49M | -18.45%-2.78B | -529.69M | -242.88%-2.34B | -683.37M |
| Gross profit | 7.20%814.76M | -21.85%1.53B | 760.06M | 34.86%1.96B | 53.91%438.71M | 11.92%1.46B | 285.04M | 227.94%1.3B | 396.73M |
| Selling expenses | -42.69%-150.15M | -201.64%-395.14M | ---105.23M | -115.87%-131M | -93.11%-15.83M | -217.30%-60.68M | ---8.2M | -77.43%-19.13M | ---10.78M |
| Administrative expenses | -17.87%-257.38M | -21.36%-510.25M | ---218.36M | -44.07%-420.45M | -65.00%-87.32M | 18.58%-291.85M | ---52.92M | -446.41%-358.44M | ---65.6M |
| Research and development expenses | 2.71%-14.13M | -105.66%-33.76M | ---14.52M | -358.45%-16.42M | -473.03%-1.74M | ---3.58M | ---304K | ---- | ---- |
| Revaluation surplus | ---- | -91.49%-145.22M | ---145.22M | ---75.84M | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | ---- | -91.49%-145.22M | ---145.22M | ---75.84M | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -26.64%31M | 291.04%193.42M | --42.25M | -10.45%49.46M | 112.49%7.71M | 6,322.79%55.24M | --3.63M | 7.90%860K | --797K |
| Operating profit | 32.96%424.11M | -53.00%643.73M | 318.98M | 18.54%1.37B | 50.29%341.52M | 24.99%1.16B | 227.25M | 187.83%924.34M | 321.15M |
| Financing cost | 22.67%-2.06M | -16.60%-4.31M | ---2.66M | 19.19%-3.69M | 14.51%-978K | -71.00%-4.57M | ---1.14M | -158.41%-2.67M | ---1.03M |
| Share of profits of associates | ---- | ---17.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profit from joint venture company | -22.34%-8.48M | ---- | ---6.93M | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---368K | ---- | ---- |
| Earning before tax | 33.68%413.57M | -54.47%621.84M | 309.38M | 18.69%1.37B | 50.86%340.54M | 24.85%1.15B | 225.73M | 187.92%921.67M | 320.11M |
| Tax | -14.00%-80.65M | 33.92%-142.11M | ---70.75M | -15.64%-215.07M | -51.79%-55.45M | -29.92%-185.99M | ---36.53M | -74.64%-143.15M | ---81.97M |
| After-tax profit from continuing operations | 39.51%332.91M | -58.31%479.73M | 238.63M | 19.28%1.15B | 50.68%285.09M | 23.92%964.76M | 189.2M | 226.91%778.52M | 238.14M |
| Earning after tax | 39.51%332.91M | -58.31%479.73M | 238.63M | 19.28%1.15B | 50.68%285.09M | 23.92%964.76M | 189.2M | 226.91%778.52M | 238.14M |
| Minority profit | 343.39%7.01M | -34.81%7.54M | --1.58M | 10.78%11.57M | 122.25%3.46M | -54.00%10.44M | --1.56M | -39.57%22.7M | --37.57M |
| Profit attributable to shareholders | 37.48%325.9M | -58.55%472.18M | 237.05M | 19.37%1.14B | 50.09%281.64M | 26.26%954.32M | 187.65M | 276.82%755.82M | 200.58M |
| Basic earnings per share | 24.16%0.221 | -65.75%0.336 | 0.178 | 2.83%0.981 | 50.00%0.282 | 25.20%0.954 | 0.188 | 160.07%0.762 | 0.293 |
| Diluted earnings per share | 24.86%0.221 | -65.85%0.335 | 0.177 | 0.981 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.